Finland· FI-REL-REL62245
Winrevair
A sotatercept product containing sotatercept, registered in Finland by Merck Sharp & Dohme B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Sotatercept is registered in 11 of 19 countries.
Countries holding a registration under ATC C02KX06 (sotatercept), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 5 of them publish a price we can compare per daily dose
Sotatercept · ATC C02KX06
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- United Kingdom
Price per daily dose
What a daily dose of sotatercept costs, country by country.
Normalised to the WHO defined daily dose (1 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Sotatercept · price per daily dose (1 mg)
USD · FX 28 Sept 2026
- CH Switzerland$167.27
The record
At a glance
Fimea (Finland)- Active substance
- Sotatercept
- Manufacturer
- Merck Sharp & Dohme B.V.
- Country
- Finland (FI)
- ATC code
- C02KX06
- ATC class
- Sotatercept
- Defined daily dose
- 1 mg, P
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
121 interactions on record for sotatercept.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sotatercept · interactions on record
121 records
121 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Sotatercept in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaWINREVAIRMerck Sharp & Dohme B.V., Haarlem
- SwitzerlandWinrevair 45 mg, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungMSD Merck Sharp & Dohme AG
- BelgiumWinrevair 45 mgMerck Sharp & Dohme
- IcelandWinrevairMerck Sharp & Dohme B.V.*
- PolandWinrevairMerck Sharp & Dohme B.V.
- SwedenWinrevair 45 mg Pulver och vätska till injektionsvätska, lösningMerck Sharp & Dohme BV
- United StatesWINREVAIRMerck Sharp & Dohme LLC
- IrelandWinrevair 45 mg powder and solvent for solution for injectionMerck Sharp & Dohme BV,
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Winrevair
- Liechtenstein · Winrevair
- Norway · Winrevair
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/80eaafff-dbbe-4db3-8236-193e4e2c53cf GET /v1/drugs/80eaafff-dbbe-4db3-8236-193e4e2c53cf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektiokuiva-aine ja liuotin, liuosta varten",
"route": "Ihon alle",
"ddd_unit": null,
"strength": "60 mg",
"atc_label": "sotatersepti",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/24/1850/003-004",
"fimea_rel_id": "REL62245",
"authorised_at": "2024-08-22"
}See everything about sotatercept.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.